ASPET’s Publications Committee is seeking the next Editor-in-Chief of Drug Metabolism and Disposition (DMD). Dr. Xinxin Ding, Editor-in-Chief of DMD, will step down from his position at the end of 2026, having completed the maximum two-term limit as Editor. The deadline for nominations is 5:00 PM ET on June 1, 2026. Self-nominations are welcome.

ASPET Editors-in-Chief serve for a three-year term that can be renewed for one additional three-year term. The position includes an honorarium. The peer-review process is managed jointly by ASPET and Elsevier using Editorial Manager, an online manuscript submission and peer review system. Editors-in-Chief also serve as members of ASPET’s Publications Committee.

Nominees must be an ASPET member in good standing and should have served on an editorial board. Before nominating a candidate, please make sure the person is willing to serve. All nominations should include a CV and a brief letter from the nominator (on their own behalf if self-nominating) expressing why this person would be a good candidate. A lengthier vision statement will be requested from candidates advancing to the interview stage.

The selection process will include online interviews with the top candidates and is expected to be completed no later than mid-September 2026. The incoming Editor-in-Chief will begin working with the outgoing Editor-in-Chief and ASPET staff during the fall and will assume all responsibilities of the Editor-in-Chief effective January 1, 2027.

Nominations, including a brief supporting statement and the candidate’s CV, should be sent to Maria Pasho, ASPET Director of Publications, at mpasho@aspet.org. Receipt of confirmation will be forthcoming.